“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...
Non-active site mutations such as L50F are crucial for restoring the viral fitness of SARS-CoV-2 main protease. Here, the authors use full-length Mpro protein as substrate and demonstrate that ...
Pfizer will pay nearly $60 million to settle claims that its subsidiary Biohaven used illegal kickbacks to drive sales of its migraine medicine Nurtec ODT … ...
Pfizer acquired Biohaven for $11.6bn in October 2022 based on a strong sales forecast for Nurtec ODT. Image credit: Shutterstock/Molly Woodward. Pfizer has agreed to pay $59.7m to resolve illegal ...
Pfizer ended the Nurtec speaker programs after paying $11.5 billion to buy Biohaven. "Patients deserve to know that their doctor is prescribing medications based on their doctor’s medical ...
Biohaven Pharmaceutical Holding, from March 2020 through September 2022, selected certain healthcare providers to be part of a group to promote its drug Nurtec ODT, a migraine treatment ...
NEW YORK (Reuters) - Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks so doctors would prescribe the ...
For this analysis, therefore, we’re focusing on the most highly cited papers that were published in 2023 by the top ten journals and conference proceedings, to identify research that has made a ...
Harry and former senior lawmaker Tom Watson are suing News Group Newspapers over alleged unlawful activities carried out by journalists and private investigators working for its papers ...
Last week, ET reported that early investors Lightspeed Venture Partners and others are looking to sell stakes in the Gurgaon-based firm while Peak XV Partners has already sold shares worth $80-90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback